A Focus on Developed Healthcare Systems: Analyzing the Gastrointestinal Drugs Market Region and Biologic Penetration
A regional assessment of the Gastrointestinal Drugs Market region confirms its strong concentration in areas with advanced, well-funded healthcare systems capable of supporting high-cost chronic disease management. North America and Europe account for the largest revenue share, a dominance driven by the high prevalence of IBD and GERD, the established infrastructure of GI specialists, and,...
0 Σχόλια 0 Μοιράστηκε 811 Views 0 Προεπισκόπηση